SPP1 and neoplasm: SPP1 (Osteopontin) is secreted by tumour cells and myeloid cells and is associated with aggressiveness and immune suppression in the TME53 and has been reported as enriched in pre-treated OAC tumours which did not respond to neoadjuvant chemoradiotherapy28.